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USE OF CLONAZEPAM  AND AVOIDANCE OF  SLEEP DEPRIVATION 
IN THE TREATMENT  OF   JUVENILE MYOCLONIC EPILEPSY
Abstract
Objectives  
Juvenile Myoclonic Epilepsy(J.M.E.) needs life-long anti-epileptic drug (AED) 
treatment. Of various drugs tried in this condition, valproate effectively treats all 
types of seizures seen in J.M.E.
Among valproate side effects, neural tube defects (NTD) in the offspring, is a 
deterring factor in its use in childbearing period. To avoid NTD, most authorities 
advise on switching to AED drug before conception.As well, the effects of 
valproate on male fertility is feared of.
Clonazepam controls only the myoclonic jerks, leaving the patients unprotected 
and susceptible to generalized seizures, which mostly occur in the morning 
after sleep deprivation. Sleep deprivation is the most prevalent precipitating 
factor for generalized seizures in these patients.
Materials &Methods
Between Jan 2003 & April 2008, 15 newly diagnosed JME patients (9 girls, 6 boys), 
were given clonazepam (1.0-4.0 mg) at bedtime, and were compared to 16 
patients on valproate treatment. All were advised to avoid sleep deprivation.
Results
This study showed, all patients in the clonazepam  group, (100 %) had full 
control of  their myoclonic jerks; 4(26.6%) had breakthrough episodes of 
generalized seizures, provoked by sleep deprivation; the rest (11,73.4 %), were 
in full remission of their myoclonic and generalized seizures. In control group, 
2(12.5 %), had episodes of breakthrough, sleep-deprived, generalized seizures;the 
rest(14, 87.5%) were in remission. Statistically, there was no significance between 
the results in both groups.
Clonazepam side effects were limited to mild to moderate drowsiness in the 
morning, eliminated by giving the dose earlier at night.
Conclusion
The study suggests that if J.M.E. patients avoid sleep deprivation, they can be 
treated with clonazepam alone to avoid side effects of valproate.
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Introduction 
Juvenile Myoclonic Epilepsy (of Janz) is a well known epileptic syndrome for its 
propensity to affect preadolescent and adolescent age groups (1, 2, 3). Although 
idiopathic and easily controlled by anti-epileptic drugs, it relapses whenever the drug 
is withdrawn; hence a life-long treatment is usually is needed, which exposes the 
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patients to potential side effects of the drugs, especially 
in  female patients (4, 5, 6, 7, 8, 9). Of various AED’s 
used, Valproate ranks first as the drug of choice, because 
it easily controls all three seizure types (genralized, 
absence and myoclonic) seen in J.M.E(3, 5, 6). However 
it has potential side effects including, GI disturbances, 
pancreatitis, endocrine, and teratogenic and cognitive 
side effects on the offspring. Neural tube defects, 
mainly meylomeningocele, are seen in as high as 6% of 
offsprings of mothers  on valproate during pregnancy, 
especially when on doses exceeding 1000mg/day (4, 7, 
8, 10, 11); other  effects include: midline defects such 
as hypospadias, partial agenesis of corpus callosum, 
ventricular septal defects; as well the effects of Valproate 
on infant neurodevelopment are well feared of (9, 12). 
There are concerns about the effects of valproate on 
male fertility (9). Hence many authorities advise on 
switching valproate to a safer drug before conception, 
like topiramate or lamotrigine, or discontinue valproate 
before conception and cautiously give anti-myoclonic 
AED’s during pregnancy for those with predominantly 
myoclonic  episodes (3, 6, 9).
Clonazepam, a long-acting benzodiazepine, controls 
the myoclonic jerks, but leaves the patient unprotected 
for the generalized seizures, which ususally occur after 
a period of sleep deprivation, (14, 15). The generalized 
seizures are  usually heralded by myoclonic jerks.
Sleep deprivation is a potent precipitating factor for 
generalized seizures in these patients, usually which 
occur early in the morning after a period of sleep 
deprivation for exam tests, wedding ceremonies, or 
Ramadan fasting.
The purpose of study was to see if a combination of 
clonazepam and total avoidance of sleep deprivation could 
prevent the occurrence of generalized seizure episodes 
in JME, hence obviate the need to use valproate.
Materials & Methods
Between January 2003 and April 2008, among patients 
seen in the author’s private clinic, fifteen patients (9 girls, 
6 boys), clinically diagnosed as J.M.E. were randomly 
selected as the study group. Evaluation consisted 
of history, physical and neurological examination, 
and  a conventional  EEG performed  by standard 10-
20 system, using a Nyhon-Cohden EEG (Japan), or 
Neuroscan LT (USA) machine. However, EEG was not 
used as a criterion for patients’ selection. History for 
early morning myoclonic jerks, followed by generalized 
seizure, was the basis for the diagnosis of J.M.E. Sixteen 
other  patients (10 girls and 6 boys) on sodium valproate 
treatment, served as control group for the period of 
study. Written consents were obtained from the  patients 
in study group.
Patients in study group were given titrating doses of 
clonazepam, 1-4 mg doses, as the sole anti-epileptic 
drug, at night 1 hour before retiring, aimimg at full 
control of myoclonic jerks. Control patients received 
sodium valproate, 15-20 mg/kg/day in 2 or 3 divided 
doses, to be taken after meals.
Patients in both groups were advised to avoid sleep 
deprivation and interruption, and were monitored for AED 
side effects. Those in study group who had breakthrough 
seizures were switched to sodium valprate. Patients in 
study group had periodic tests of complete blood count 
(CBC); Valproate group underwent periodic assessment 
of CBC, platelet count and liver function tests. Fisher’s 
Exact Test was used for statistical analysis. An English 
language literature search was made.
Results
Age of the patiests ranged from 10 years to 23 years. 
Girls outnumbered in both groups. All patients had 
normal neurological examinations. None of the female 
patients in both groups were married. Most had normal 
awake EEG’s (only 4 abnormal EEG’s, 12.9%) in both 
groups.  During period of study and follow up, of patients 
in study group, 11 patients (73.4 %), experienced full 
remission (no generalized seizure). The rest (4, 26.6 %) 
had breakthrough generalized seizures at early morning, 
always after a period of interrupted or incomplete sleep. 
They were switched to valproate regimen for the rest of 
the study period, with no further breakthrough seizures.
In the control group, 2(12.5 %) had breakthrough 
early morning generalized seizures, in all after sleep 
deprivation;the rest (14, 87.5 %), had full remission.
None of the subjects in study or control group consumed 
alcohol.
In both groups myoclonic jerks were fully controlled 
with either clonazepam or valproate.
Side effects of clonazepam were limited to early morning 
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drowsiness in study group in all subjects when the dose 
was titrated up to 4 mg/day. Drowsiness lessened or 
subsided as the dose was given earlier at night and as the 
regimen continued. None of the patients on clonazepam 
had any change in hemogram.
Side effects of sodium valproate in control group and 
those switched to it from study group were: abdominal 
pain in10 patients, obesity in 4, hair loss in 6, and 
menstrual irregularities in 3 patients. None of the patients 
on valproate had changes in hemogram or liver function 
tests during the period of study. Statistically, there were 
no significances between the two groups in control of 
generalized seizures (P-value = 0.394)
Discussion
J.M.E is the only idiopathic seizure disorder in which 
anti-epileptic drugs must be continued life –long (1, 2, 
3), although myoclonic jerks may subside later in life 
(19). Valproate controls all three types of seizures, but 
exposes the patient to various side effects, like polycystic 
ovary syndrome, obesity, hair loss, and decreased sperm 
count in the male, and neural tube defects and neuro-
developmental delay in the offspring (5-12). Various 
other drugs have been tried, but each has its caveat, or 
does not cover all aspects of the disease. For example, 
carbamazepine controls the GTCS component, but 
may exacerbate absence and myoclonic seizures(3).
Lamotrigine, while controlling absence  and generalized 
seizures(13), may aggravate the myoclonic component, 
especially at higher concentrations(16,17), and has 
been associated with non-syndromic cleft palate in the 
offspring(22). Levetiracetam is recently another choice 
for treatment of JME, and  although it may become  soon 
the drug of first choice, but it is expensive in Iran(18, 23, 
24). Clonazepam readily controls the myoclonus, and 
sometimes the absence, but is relatively ineffective on 
GTCS’s (3, 6,10,11).
Since most of the generalized seizures in these patients 
is provoked by sleep deprivation, its avoidance per se 
could potentially prevent generalized seizures, mostly 
seen at early morning.
A literature search did not yield any comparable study. 
Clonazepam per se has not been yet used in the treatment 
of JME for the fear of masking the myoclonias which 
is a warning sign for these patients to take rest and use 
a rapid-acting benzodiazepine before the generalized 
seizure sets in (1, 2, 3).
This study shows that the potential side effects of valproic 
acid could be avoided by a combination of clonazepam 
and strict avoidance of sleep deprivation.
The main side effects of clonazepam are drowsiness and 
excessive oro-tracheal secretions (14,15). Drowsiness, 
seen in the study group early in the morning, was 
eliminated by giving the appropriate doses several hours 
before sleep. No other side effects were seen. Regular 
CBC done showed no hematologic derangement. On the 
other hand patients on valproate showed various side 
effects. No particular pregnancy risks has been found in 
association with clonazepam (14), except when given 
with other AED’s as polytherapy(10). Although the result 
of this study is not statistically siginificant regarding 
control of seizures (P value= 0.394), it seems prudent 
to advise cooperative and compliant  J.M.E. patients to 
use clonazepam along with strict sleep precautions, life –
long, to avoid valproic acid side effects. Sleep precaution 
is mandatory, especially during study years, wedding 
ceremonies, and during child nurturing periods, when 
sleep deprivation or interuption episodes are usual.
In conclusion, If used with strict sleep precautions, 
clonazepam can substitute sodium valprate, thus avoiding 
its potentially  harmful  side effects.
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Table 1. Comparrison of charachteristics of  Study & 
Control Group
P Value ControlGroupStudy Group
16 (37.5%)6 (40%)Male
10 (62.5%)9 (60%)Female
0.39414 (87.5%)11 (73.4%)No GeneralizedSeizures
2 (12.5%)4 (26.6%) GeneralizedSeizures
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